DOKTER SOLANGE LINTERMANS
ActiveFrom the official registers: KBO 13 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
DOKTER SOLANGE LINTERMANS has been active since 2013 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €329,015 and a net result of €50,758. Equity is growing by about 3.9% per year across the filed financial years. Its solvency ranks better than 27% of 3,024 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
Official details
KBO- Status
- Active since 24-06-2013 Normal situation
- Legal form
- Private limited company
- Registered office
- Jos Smolderenstraat 46, 2000 Antwerpen
- Activity
- Specialist medical practice NACE 86220
- Establishment unit
- 2.220.650.001 2000 Antwerpen, since 24-06-2013
- Financial year end
- 31 December
- Peppol
- Reachable since 24-11-2023
How it is doing
- Bankruptcy probabilitywithin 12 months
- < 0.1%
Annual accounts 2025
- Gross margin
- €152,206
- ▲ 1.2%
- Turnover
- ≈ €280,000
- estimated
- Profit
- €50,758
- ▲ 9.1%
- Equity
- €329,015
- ▲ 18.2%
- Total assets
- €1.1m
- ▼ 10.0%
2025 accounts filed 28 days late
Filed on 28-08-2026at the National Bank
Why 91raises riskLiquidity: current ratio 0.15, cash €21,898lowers riskSize: total assets €1.1mSector: Human health activities (NACE 86)Figures for financial year 2025 (filed 01-09-2026)Show the evidence
Checked score
Score 2025
91
/ 100
Excellent
Probability in this band: under 0.55%
Financially better than 28% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Average
Solvency
55+8
equity 29.5% of total assets
Liquidity
35+3
short-term debt 38.0% · cash 2.0%
Profitability
74+1
return on assets 4.6%
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: < 0.1%lowest value
12-2024: < 0.1%● unchanged vs 11-2024lowest value
01-2025: < 0.1%● unchanged vs 12-2024lowest value
02-2025: < 0.1%● unchanged vs 01-2025
03-2025: < 0.1%● unchanged vs 02-2025
04-2025: < 0.1%● unchanged vs 03-2025
05-2025: < 0.1%● unchanged vs 04-2025
06-2025: < 0.1%● unchanged vs 05-2025
07-2025: 0.1%▲ +0.1 percentage points vs 06-2025
08-2025: 0.1%● unchanged vs 07-2025
09-2025: 0.1%● unchanged vs 08-2025
10-2025: 0.1%● unchanged vs 09-2025
11-2025: 0.1%● unchanged vs 10-2025
12-2025: 0.1%● unchanged vs 11-2025
01-2026: 0.1%● unchanged vs 12-2025
02-2026: 0.1%● unchanged vs 01-2026
03-2026: 0.1%● unchanged vs 02-2026
04-2026: 0.1%● unchanged vs 03-2026
05-2026: 0.1%● unchanged vs 04-2026
06-2026: 0.1%● unchanged vs 05-2026
07-2026: 0.1%● unchanged vs 06-2026
08-2026: 0.3%▲ +0.2 percentage points vs 07-2026highest value
09-2026: < 0.1%▼ -0.3 percentage points vs 08-2026
10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €25,000 on 30-day terms is acceptable
Liquidity insufficient (current ratio 0.15, compared with 0.25 in 2024, below 1; short-term debt: 38% and cash: 2% of total assets), and 70.5% of the assets are financed with debt and provisions.
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 26% on solvency, 7% on liquidity, 18% on profitability and 62% on growth.
The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Five signals.
lowers riskraises riskneutral
neutral · A punctual record breaks
This company filed 3 consecutive financial years on time. The year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-08-2026, 28 days late. Weigh it accordingly: of the companies that move to filing 1 to 90 days late, 1.41% are now bankrupt, dissolved or in another special legal status, below the 1.66% of all filers. It is a change in behaviour, not evidence of elevated risk.
NBB · 10 filingsDeviation from the deadline
2025
28 days late
2024
44 days early
2023
78 days early
2022
34 days early
2021
29 days late
2020
31 days late
2019
28 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 14 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 27 June (4 of the last 5 filed years within 62 days of that day).
Companies Code · seven monthsWhere today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
Documents
Annual accounts at the NBB
- Annual accounts 2025filed on 28-08-2026
- Annual accounts 2024filed on 17-06-2025
- Annual accounts 2023filed on 14-05-2024
- Annual accounts 2022filed on 27-06-2023
Acts in the Belgian Official Gazette
All publications in the Belgian Official GazetteArticles and registers
- Coordinated articles of associationnotaries' database
- Entry in the KBO registerKBO Public Search
Key facts about DOKTER SOLANGE LINTERMANS
- What is the company number of DOKTER SOLANGE LINTERMANS?
- 0535.928.760. In Belgium the VAT number is the company number with BE in front: BE 0535.928.760.
- Where is DOKTER SOLANGE LINTERMANS based?
- The registered office is at Jos Smolderenstraat 46, 2000 Antwerpen.Company details
- What does DOKTER SOLANGE LINTERMANS do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of DOKTER SOLANGE LINTERMANS?
- Private limited company (BV).
- When was DOKTER SOLANGE LINTERMANS founded?
- On 24-06-2013.
- Is DOKTER SOLANGE LINTERMANS still active?
- Yes, DOKTER SOLANGE LINTERMANS is an active enterprise in the KBO register.
- What is the turnover of DOKTER SOLANGE LINTERMANS?
- ≈ €280,000 in financial year 2025. Estimated from the gross margin of €152,206: probably between €240,000 and €380,000, based on 43 comparable companies, NACE 86220.Financials
- Is DOKTER SOLANGE LINTERMANS profitable?
- In financial year 2025, DOKTER SOLANGE LINTERMANS made a profit of €50,758.
- Where can I find the annual accounts of DOKTER SOLANGE LINTERMANS?
- DOKTER SOLANGE LINTERMANS filed 13 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
- When are the next annual accounts of DOKTER SOLANGE LINTERMANS due?
- By 31-07-2027, for financial year 2026.Timeline
Companies related to DOKTER SOLANGE LINTERMANS
Go further with this company
How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.